Niantic, CT, United States of America

Annabella Villalobos

This inventor holds 1 USPTO granted patent. Top assignee: Pfizer Corporation. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Annabella Villalobos. Retrieved from https://idiyas.com/inventor/annabella-villalobos

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Spotlight: Annabella Villalobos

Introduction

Annabella Villalobos, based in Niantic, CT, is a remarkable inventor recognized for her contribution to the field of chemistry. With her innovative work focusing on imidazole derivatives, she has made a significant impact within the pharmaceutical industry.

Latest Patents

Annabella holds one patent that showcases her expertise in the development of imidazole derivatives. This invention is aimed at advancing drug formulation and enhancing the efficacy of therapeutic agents.

Career Highlights

As an integral part of the Pfizer Corporation, Annabella has dedicated her career to research and development. Her work often emphasizes the importance of innovation in creating solutions for complex medical challenges.

Collaborations

Throughout her career, Annabella has collaborated with notable colleagues, including Mark Allen Sanner and Chris John Helal. These partnerships illustrate the collaborative spirit within the Pfizer Corporation, further enhancing the quality of their research outcomes.

Conclusion

Annabella Villalobos stands out as an inspiring inventor who continues to pave the way in pharmaceutical innovation. Her commitment to developing new solutions demonstrates the vital role of inventors in shaping the future of medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…